Drug intelligence / Profile preview

3'-deoxy-3'-aminothymidine monophosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

**Description:** \n3'-deoxy‐3'-aminothymidine monophosphate is a synthetic nucleotide analog and phosphorylated derivative of thymidine. It features an amino group at the 3' position in place of the usual hydroxyl group and is phosphorylated at the 5' position. This compound belongs to the class of pyrimidones and has been studied as an experimental molecule with potential applications in antiviral therapy due to its structural similarity to natural nucleotides. Its mechanism likely involves incorporation into DNA or RNA chains by viral polymerases or interference with nucleic acid synthesis; however, it is not approved for clinical use and remains primarily a research tool[1][2]. \nThe compound has also been identified as a catabolite related to certain antiretroviral drugs (such as AZT), where it may contribute to cytotoxicity[9].

Other names
3'-Amino-3'-deoxythymidine 5'-monophosphate(((2S,3S,5R)-3-amino-5-(4-hydroxy-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl)methoxy)phosphonic acid{[(2S,3S,5R)-3-amino-5-(4-hydroxy–5-methyl–2–oxo–1,2-dihydropyrimidin–1–yl)oxolan–2–yl]methoxy}phosphonic acid42214‑32‑4Thymidine, 3′‑amino‑3′‑deoxy-, 5′-(dihydrogen phosphate)1-{(4S,5S,2R)-4-Amino‑5-[phosphonooxy)methyl]oxolan‑2‑yl}-5-methyl−1,3-dihydropyrimidine−2,4-dione
02

Targets

POLE (DNA polymerase epsilon)TMPK (Thymidine monophosphate kinase (Mycobacterium tuberculosis))RT (Viral reverse transcriptase)

Beyond the preview

Go deeper on 3'-deoxy-3'-aminothymidine monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3'-deoxy-3'-aminothymidine monophosphate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call